NCT00043446View on ClinicalTrials.gov

Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

PHASE2UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2002

Conditions
Ovarian Neoplasms
Interventions
DRUG

intravenous T900607-sodium

Trial Locations (5)

14263

Roswell Park Cancer Center, Buffalo

90033

USC Women's and Children's Hospital, Los Angeles

92037

Scripps Health Center, La Jolla

94115

University of California San Francisco, San Francisco

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Tularik
All Listed Sponsors
lead

Tularik

INDUSTRY

NCT00043446 - Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer. | Biotech Hunter | Biotech Hunter